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Abstract 
Coordinated changes of DNA (de)methylation, nucleosome positioning and chromatin 
binding of the architectural protein CTCF play an important role for establishing cell type 
specific chromatin states during differentiation. To elucidate molecular mechanisms that link 
these processes we studied the perturbed DNA modification landscape in mouse embryonic 
stem cells (ESCs) carrying a double knockout (DKO) of the Tet1 and Tet2 dioxygenases. 
These enzymes are responsible for the conversion of 5-methylcytosine (5mC) into its 
hydroxymethylated (5hmC), formylated (5fC) or carboxylated (5caC) forms. We determined 
changes in nucleosome positioning, CTCF binding, DNA methylation and gene expression in 
DKO ESCs, and developed biophysical models to predict differential CTCF binding. 
Methylation-sensitive nucleosome repositioning accounted for a significant portion of CTCF 
binding loss in DKO ESCs, while unmethylated and nucleosome-depleted CpG islands were 
enriched for CTCF sites that remained occupied. A number of CTCF sites also displayed 
direct correlations with the CpG modification state: CTCF was preferentially lost from sites 
that were marked with 5hmC in wild type cells but not from 5fC enriched sites. In addition, 
we found that some CTCF sites can act as bifurcation points defining the differential 
methylation landscape. CTCF loss from such sites, e.g. at promoters, boundaries of 
chromatin loops and topologically associated domains (TADs), was correlated with DNA 
methylation/demethylation spreading and can be linked to downregulation of neighbouring 
genes. Our results reveal a hierarchical interplay between cytosine modifications, 
nucleosome positions and DNA sequence that determines differential CTCF binding and 
regulates gene expression. 
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Introduction 
Transcription factor (TF) binding and covalent DNA cytosine modifications like methylation 
(5mC), hydroxymethylation (5hmC) and formylation (5fC) occur in a cell type specific 
manner, and are linked to the cellular gene expression program. Dependencies between 
DNA methylation and specific readers and effectors are well established (Schubeler 2015; 
Zhu et al. 2016). However, the molecular details of these interactions are often not well 
understood (Domcke et al. 2015; Yin et al. 2017). One important example of differential 
binding is the architectural protein CTCF that has functions in the direct regulation of 
transcription and the organisation of 3D genome architecture (Merkenschlager and Nora 
2016; Nora et al. 2017; Rao et al. 2017). A number of studies have linked differential CTCF 
binding to DNA (de)methylation (Stadler et al. 2011; Wang et al. 2012; Feldmann et al. 2013; 
Kasowski et al. 2013; Plasschaert et al. 2013; Teif et al. 2014; Maurano et al. 2015; Viner et 
al. 2016; Hashimoto et al. 2017), although in many cases it remains unclear what is the 
cause and what is the consequence. About 40% of CTCF binding variability between 
different human cell types is correlated with DNA methylation changes (Wang et al. 2012). 
The methylation of a CTCF-dependent boundary element controlling imprinted expression of 
the Igf2 gene has become a classical paradigm for the role of DNA methylation in reducing 
CTCF binding (Bell and Felsenfeld 2000). A similar effect of DNA methylation was reported 
for the Dmpk locus, where deregulation of CTCF binding is linked to myotonic dystrophy 
(Filippova et al. 2001). DNA methylation can also decrease CTCF binding at intragenic sites 
involved in the regulation of splicing (Marina et al. 2016). However, not all CTCF binding 
sites contain CpG dinucleotides that can be methylated. In many cases the causalities might 
be reverse: CTCF binding changes first and affects DNA methylation in the surrounding 
regions (Stadler et al. 2011; Maurano et al. 2015; Schubeler 2015). In the latter scenario it 
remains largely unknown what determines the differences in CTCF binding in the first place. 
Previously, we proposed that a 5mC/5hmC/5fC switch can change the stability of 
nucleosomes at CTCF sites in a differentiation-dependent manner, thereby disturbing CTCF 
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binding (Teif et al. 2014). Here, we used double knockout (DKO) ESCs deficient for Tet1 and 
Tet2 (Dawlaty et al. 2013) to test this mechanism directly. TET1 and TET2 are responsible 
for the conversion of 5mC to 5hmC, 5fC and 5caC (Tahiliani et al. 2009; Ito et al. 2011), and 
are required for ESC lineage specification (Koh et al. 2011). In DKO cells 5hmC is absent 
(Dawlaty et al. 2013), which allowed us to investigate direct effects of 5hmC loss on the 
redistribution of 5mC, CTCF and nucleosomes, as well as the corresponding changes in 
gene expression. 
 
Results  
Loss and gain of nucleosomes are linked to DNA methylation  
We first tested our previous hypothesis that a 5mC/5hmC/5fC switch affects the nucleosome 
stability and their occupancy landscape (Teif et al. 2014) using MNase-assisted H3 ChIP-
seq. We mapped regions with changing average nucleosome occupancy in DKO versus wild 
type (WT) cells upon Tet1/2 depletion within a 100 bp sliding window. This analysis identified 
216,278 regions with increased and 22,365 regions with decreased nucleosome occupancy. 
We then calculated the average DNA methylation profiles in WT and DKO cells around the 
centers of these regions (Figure 1A and B; also see Methods Online and Figure S1). The 
regions with decreased nucleosome occupancy were characterised by decreased DNA 
methylation, while those with increased occupancy showed increased methylation. In order 
to clarify the fine structure of DNA methylation inside and around nucleosomes, average 
methylation profiles around the centers of all nucleosomes were calculated. First, we 
considered nucleosomal DNA fragments that showed an overlap of at least 95% between 
WT and DKO cells (Figure 1C). In this case, methylation was much higher inside 
nucleosomes, smoothly increasing from the middle of the nucleosome towards the ends, 
then dropping at the nucleosome ends and oscillating up to a distance of ~1 kb from the 
nucleosome center with a period equal to the nucleosome repeat length (NRL). Secondly, 
this calculation was repeated for nucleosomes that shifted by >5% (Figure 1D) or >30% 
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(Figure 1E). Methylation profiles were significantly changed around nucleosomes that shifted 
between WT and DKO ESCs, and we were able to track down methylation changes to the 
regions inside nucleosomes that undergo a shift >30% (Figure 1E). Thirdly, all nucleosomes 
in DKO cells were considered. In this case the methylation profile inside the nucleosome 
was reversed compared to the WT profile (Figure 1F). We obtained a similar picture, albeit 
without oscillations, when considering only nucleosomes inside CpG islands (Figure S2). 
Next, we quantified changes of nucleosome occupancy at different genomic features. While 
the majority of regions increased their nucleosome occupancy in DKO ESCs, a significant 
number of functional genomic elements (promoters, enhancers, CpG islands, regions 
marked by 5hmC in WT cells, 5hmC-to-5mC substitutions in DKO ESCs and TAD 
boundaries) showed decreased nucleosome occupancy upon Tet1/2 knockout (Figure 1G, 
S3-S4 and S5A). Nucleosome loss was particularly pronounced for CpG islands and regions 
marked by 5fC and TET1 in WT cells. Regions marked by 5fC in WT ESCs (Song et al. 
2013) were characterised by much stronger nucleosome loss in comparison with those 
marked by 5hmC or 5caC. This effect was also confirmed using another 5fC dataset with 
single-base pair resolution (Xia et al. 2015), which showed a 2.52-fold enrichment of regions 
with decreased nucleosome occupancy and 0.25-fold depletion of regions with increased 
nucleosome occupancy at 5fC sites. 
A Gene Ontology (GO) analysis of genomic regions that lost nucleosomes in DKO ESCs 
showed an enrichment for pluripotency-related processes (PluriNetWork, p = 0.0087) and for 
DNA sequence motifs of EGR1 (p = 0.0016) (Supplemental Tables ST1 and ST2). EGR1 is 
known to regulate hematopoietic differentiation (Nguyen et al. 1993). We found the 
expression of Egr1 slightly increased in DKO cells (1.26-fold, p = 6.4 × 10-4) (Supplementary 
Table ST3). This may suggest that Tet1/2 depletion affects differentiation pathways, in 
accordance with the hematopoietic differentiation defects observed in Tet2 deficient mice (Li 
et al. 2011). Regions that gained nucleosomes were enriched for binding motifs of the TATA 
box binding protein TBP (p = 0.037) (Supplemental Table ST5), although no changes in Tbp 
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expression were observed. In general, genes significantly upregulated in DKO ESCs were 
enriched for the GO categories meiosis (p = 1.6 × 10-5), myosin (p = 6.4 × 10-4), 
differentiation (p = 0.0016), hematopoietic cell lineage (p = 7.3 × 10-4) and immunity 
(p = 0.0028). Upregulated genes that gained nucleosomes at their promoters also followed 
this trend, with an additional enrichment for glycoproteins (p = 1.6 × 10-4) (Supplemental 
Tables ST4-ST6). Genes significantly downregulated in DKO cells were not enriched with 
clusters of GO terms using the same criteria.  
Next, we looked at the genome-wide statistics of methylome changes. Any gain of 5mC in 
DKO ESCs reflects methylated cytosine, whereas the observed loss of 5mC in DKO cells 
can be either due to the loss of 5hmC or 5mC, since both marks are not distinguished by 
bisulfite sequencing (Huang et al. 2010). In line with the increase of average nucleosome 
occupancy we also observed a global increase in DNA methylation. 9,739,847 CpGs 
changed their methylation level from <20% in WT to >50% in DKO cells. Figures 1H and 
S5B show how 5mC was redistributed in DKO relative to WT ESCs. Gained 5mC sites were 
less frequent in CpG islands in comparison to common and lost 5mC sites. Promoters 
tended to keep their methylation status, while enhancers displayed increased levels of 
changed methylation (both lost and gained 5mC). This may indicate extensive modulation of 
gene expression by changes of DNA methylation at enhancers. 
  
Common and lost CTCF sites have different CpG patterns 
In order to study the effect of DNA methylation and nucleosome positioning on functional 
CTCF sites, we applied a stringent filter to analyse the CTCF ChIP-seq data. We considered 
only those CTCF sites that appeared in all technical and biological replicates for a given cell 
type (WT and DKO). Based on this criterion, 7,232 robustly determined CTCF sites were 
present in both cell types (“common” sites) and 3,916 robustly determined CTCF sites were 
lost in DKO ESCs compared to WT (“lost” sites; for example, regions see Figures S7-S15). 
7 
 
Only 44 sites appeared in both DKO replicates and were not found in any WT replicate 
(“gained” sites; these were not further considered in the downstream analysis). Differences 
in CTCF expression between WT and DKO cells measured by RNA-seq were below 10%, 
indicating that changes in binding do not simply reflect CTCF expression changes (Table 
ST3). Furthermore, our Western blot data showed similar CTCF abundance at the protein 
level in WT and DKO cells (Figure S6). 
For the CTCF peaks defined above we mapped the presence of the 19-bp CTCF binding 
motif and identified 18,000 common and 11,123 lost CTCF sites. On average a given peak 
contained 2-3 copies of the CTCF motif. Figures 2A and 2B show the statistics of common 
and lost CTCF sites defined by DNA motifs. Common CTCF sites were twice more 
frequently detected inside CpG islands compared to lost CTCF sites. In contrast, the 
enrichment of common/lost CTCF sites with hydroxymethylated or differentially methylated 
sites showed the opposite tendency: lost CTCF sites were significantly enriched at sites that 
changed their 5mC status. With respect to 5mC oxidation products, we found that lost CTCF 
sites were significantly more associated with 5hmC in WT ESCs than common sites, and 
significantly less associated with 5fC than common sites (Figure 2A and B).  
We then tested the hypothesis that common and lost CTCF sites have different probabilities 
to be methylated due to different CpG content. Indeed, 52% of common CTCF motifs 
contained CpGs, whereas only 42% of lost CTCF sites contained CpGs. Thus, more than 
half of the lost CTCF sites did not contain CpGs and were therefore not directly affected by 
DNA methylation. While common and lost CTCF sites were characterised by the same 
canonical CTCF motif, they had distinct differences. Lost sites, on average, showed a 
weaker match with the CTCF motif and had lower GC content in comparison to common 
sites (Figure 2C and D). The CpG content of common and lost sites showed a similar pattern 
(Figure 2E and F). Thus, common but not lost CTCF sites were surrounded by regions with 
higher GC content and enriched with CpGs, whereas lost sites had a decreased probability 
to contain CpGs inside the CTCF motif in comparison with common sites.  
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We also performed an integrated analysis of DNA methylation and CTCF binding in WT and 
DKO ESCs. The average profiles of CTCF occupancy in the vicinity of commonly methylated 
CpGs did not change upon TET knockout (Figure 3A). In contrast, CpGs that changed their 
methylation status were characterised by changes of CTCF occupancy. The most significant 
change of CTCF binding was observed for a class of CpGs changing their methylation status 
from low (average methylation <0.2) to intermediate and high (average methylation >0.5) 
(Figure 3B). DNA methylation around common and lost CTCF motifs showed characteristic 
profiles with well-defined oscillations (Figure 3C-F). The methylation level inside CTCF 
binding sites was reduced in common, but increased in lost CTCF sites (Figures 3C-F). This 
feature was characteristic for both WT and DKO 5mC profiles. Common and lost CTCF sites 
also showed different CpG patterns (Figure 2), suggesting that some of the common and lost 
sites may have different modes of CTCF binding. 
 
CTCF binding is determined by DNA sequence, methylation and nucleosome 
occupancy 
In several instances changes in CTCF binding occurred at sites with differential 
methylation/nucleosome occupancy (Figures S7-S17). To assess this relation systematically, 
we predicted differential CTCF binding based on DNA sequence, changes of methylation 
and nucleosome positioning. We calculated average CTCF occupancy profiles around 
common and lost sites for all replicate experiments (Figure S16, S18), averaged all 
replicates separately for each of the two cell types (WT and DKO) and normalised to equal 
CTCF occupancy at common sites (Figure 4A and B, S18). Lost sites were mostly present in 
DKO ESCs and, consistent with the concept of CTCF-nucleosome competition, the 
nucleosome occupancy at lost CTCF sites increased in DKO cells (Figure 4C).  
Further analysis showed that the predicted (based on DNA sequence) CTCF affinity of lost 
sites was lower than that of common sites (Figure 4D) and quantitatively reproduced the 
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experimental distribution in Figure 4B. Thus, it was possible to distinguish the subset of 
CTCF sites lost in DKO ESCs based on their weaker affinity for CTCF-DNA binding. Our 
comparison of different predictors of CTCF loss revealed that the strength of the CTCF 
binding motif was an equally good predictor as the change of nucleosome occupancy 
(AUC = 0.57 in both cases, Figure S19A). In contrast, the level of DNA methylation could not 
be used to predict CTCF loss at individual sites. Consistent with the data in Figures 2E/F the 
best predictor of CTCF loss was the CpG density in regions of 1,000 bp surrounding CTCF 
sites. CTCF binding was lost from sites surrounded by low CpG density and retained at sites 
with high CpG density (AUC = 0.65, Figure S19A). These results support our model of the 
5mC/5hmC/nucleosome switch (Figure S19B): Inside CpG islands CTCF binding is mostly 
invariant, whereas outside of CpG islands CTCF binding is determined by 
CTCF/nucleosome competition, which in turn is determined by DNA methylation through 
changes of nucleosome stability and location. 
 
DNA sequence features link CTCF binding and DNA methylation 
To further dissect the long-range effects of CpG content on CTCF binding, we analysed the 
correlation of CTCF motifs and DNA methylation. Figures 5A and 5B show average profiles 
of genome-wide predicted CTCF affinity as a function of the distance from CpGs, 
characterised by common, lost and gained methylation (Figure 5A), as well as for commonly 
unmethylated CpGs (Figure 5B). The average sequence-determined CTCF energy 
landscapes were different for all four CpG categories. CpGs unmethylated both in WT and 
DKO cells were characterised by higher CTCF binding, while methylated CpGs showed 
decreased CTCF binding. We also observed that the CTCF energy profiles around gained 
and lost 5mC regions were in counter-phase. Lost 5mC sites were characterised by a peak 
of CTCF affinity at the center, whereas gained sites were characterised by a CTCF affinity 
drop. In all four cases the CTCF energy landscape oscillated with a periodicity of 176 +/- 3bp 
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(determined by the nucleosome repeat length in those regions, which was more than 10 bp 
smaller than the genome-wide nucleosome repeat length).  
Further analysis revealed that commonly methylated/unmethylated CpGs were associated 
with very similar profiles for common and lost CTCF peaks, with some differences in CTCF 
affinity (Figure 5C, 5F). In contrast, CpGs that gained/lost methylation displayed different 
shapes (Figure 5D, 5E). These calculations were repeated for regions inside and outside of 
CpG islands, as well as inside and outside of promoters (Figures S20-S21), showing that the 
periodicity was mainly determined by the regions outside promoters and CpG islands. 
Furthermore, CTCF affinity peaks inside promoters and CpG islands were associated with 
peaks of local CpG density (Figures S20C and S21C). Thus, the connection between DNA 
methylation changes and CTCF loss appears to be dependent on the DNA sequence in a 
larger region surrounding CTCF sites. 
 
CTCF loss at functional elements near genes is linked to reduced gene expression 
Next, we analysed the effect of differential CTCF binding on gene expression (Figure 6). 
Transcripts were annotated based on their expression changes and location with respect to 
individual CTCF sites, boundaries of topologically associated domains (TADs) and chromatin 
loops reported in WT ESCs (Bonev et al. 2017). Genome-wide, we observed a tendency of 
more upregulated than downregulated transcripts in DKO cells (see the leftmost bar in 
Figure 6A). The same trend was observed inside and outside loops or TADs, both close to 
the boundaries of loops and TADs and far away from them, as long as CTCF loss was not 
taken into account (see the first four bars in Figure 6A). However, inside TADs that lost 
boundaries this relation was reversed (more transcripts were downregulated than 
upregulated), which was even more pronounced in the vicinity of these lost boundaries. 
Finally, transcripts which contained lost CTCF sites in their promoters showed an even 
stronger tendency for downregulation (see the rightmost bar in Figure 6A). This effect was 
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statistically significant in all gene classes characterised by CTCF loss described above (χ2 
test, p < 6.6 × 10-5). Thus, CTCF loss was correlated with a downregulation of gene 
expression within the corresponding domain demarcated by CTCF in WT cells. This effect 
includes whole domains that lost boundaries and has a strong distance-dependent 
component. It was more pronounced close to the lost CTCF sites compared to regions within 
the same TAD, but located distantly from lost CTCF sites (Figure 6A). 
An explanation for the observed distance-dependent effect of CTCF loss on gene expression 
could be changes of DNA methylation as a function of the distance from the lost CTCF site. 
As shown in Figures 6B-D and S22, DNA methylation averaged with a sliding window of 
500 bp yields smooth landscapes for WT and DKO ESCs that partly coincide and partly 
deviate from each other. These methylation profiles were demarcated by CTCF sites in two 
ways. Firstly, some CTCF sites were located in the summits of high-methylation peaks or the 
bottoms of low-methylation valleys. Similar behaviour has been reported previously, 
suggesting that CTCF can prime neighbouring regions for demethylation (Stadler et al. 
2011). Secondly, some CTCF sites appeared to act as boundaries for methylation 
spreading. The loss of CTCF from these sites turns them into “bifurcation points”, when on 
one or both sides of the CTCF boundary the average 5mC profiles start diverging between 
WT and DKO cells.  
In order to study the latter effect genome-wide, we analysed differentially methylated 
genomic regions (DMRs) using the DMRcaller R package (Catoni et al. 2018) with a 
scanning window of 1,000 bp for DMRs which lost (Figure 6E) and gained (Figure 6F) 
methylation in DKO cells. This analysis revealed that both “loss” and “gain” DMRs were 
preferentially demarcated by CTCF (Figures 6G-H and S23-S24), which corresponds to 
CTCF acting as a bifurcation point in our examples in Figures 6B-D and S22. In addition, 
“loss” DMRs had increased occurrence of CTCF sites in the center of the DMR, which 
corresponds to CTCF positioned at the peak summits and valley bottoms of the methylation 
landscapes in Figures 6B-D and S22. However, DNA sequence motif analysis did not reveal 
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CTCF as the top binding candidate for the regions near DMR boundaries, suggesting that 
additional TFs might be involved (Table ST7). 
The asymmetry of DNA methylation profiles surrounding CTCF sites noted in Figure 6 would 
suggest that the CTCF distribution around methylated CpGs would also be asymmetric. In 
order to find out whether such an asymmetry is hard-wired in the DNA sequence genome-
wide, we computed the predicted CTCF binding affinity around different classes of CpGs 
based on their methylation status in WT and DKO cells, and then performed k-means 
clustering of CTCF profiles of these regions (Figure S25). This analysis confirmed that 
clusters with asymmetric CTCF affinity distribution were characteristic for common or gained 
5mC sites, but not unmethylated CpGs and not for random regions (Figure S25). Thus, 
CTCF sites act as bookmarks for the demethylation process, appearing both at the 
methylation peak centers and at the boundaries, thereby separating regions of differentially 
methylated DNA.  
 
Discussion 
Mouse embryonic stem cells that lack TET1/2 enzymes display a genome-wide loss of 
5hmC and a severe deregulation of the 5mC landscape (Dawlaty et al., 2013). In the present 
study, we link CTCF binding, DNA (de)methylation and nucleosome occupancy by 
comparing wildtype ESCs with DKO ESCs that lack Tet1/2. The resulting cascade of 
downstream events can be summarized as follows (see also Figures 7A and S26): In DKO 
cells nucleosome occupancy became reduced at sites that lost 5mC and increased at sites 
that gained 5mC. The latter effect was about 10 times more frequent. Sites losing 
nucleosomes were enriched at regulatory regions related to developmental and 
differentiation-related pathways, most likely leading to additional impairment of gene 
regulation. Our analysis suggested that the 5mC/nucleosome linkage is strongest within the 
nucleosomal DNA (Figure 1) and uncovered distinct effects of 5mC, 5hmC and 5fC at 
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nucleosomes. Nucleosome loss was pronounced for regions marked by 5fC in WT cells. 
This may be related to different effects of 5fC and 5hmC on nucleosome stability. We 
reported previously that 5fC is associated with well-positioned nucleosomes, while 5hmC is 
associated with labile MNase-sensititive nucleosomes (Teif et al. 2014). A strong 
nucleosome-stabilising effect of 5fC was explained recently by the formation of non-covalent 
bonds between formylated DNA and histones (Raiber et al. 2018). Different DNA cytosine 
modifications are known to modulate physically the rigidity and geometry of the double helix, 
and thus nucleosome stability (Raiber et al. 2015; Dans et al. 2016; Ngo et al. 2016). In 
addition, the effects observed here might also be modulated by interactions with chromatin 
proteins that can selectively recognise unmodified and modified CpGs (Zhu et al. 2016).  
Significant loss of CTCF binding was observed in DKO ESCs. In the minority of cases this 
coincided with a 5mC/5hmC/5fC switch inside the CTCF binding motif, where CTCF loss 
was associated with deregulation of cytosine modifications. However, in the majority of 
cases CTCF loss was associated with a nucleosome/5mC switch in the neighbouring area 
rather than a methylation change inside the CTCF motif itself. In this context, CTCF loss 
could affect DNA methylation by removing some of the foci of methylation domains and 
some of the boundaries preventing spreading of methylation to the neighbouring areas 
(Figure 6). Thus, the interplay of DNA methylation and CTCF redistribution was not limited to 
an anticorrelation of CTCF binding and DNA methylation, as has been reported in previous 
studies (Stadler et al. 2011; Feldmann et al. 2013; Teif et al. 2014; Maurano et al. 2015). 
Rather, it included several conclusions that are summarised in Figure 7B: (i) CpG islands 
displayed a reduced frequency of CTCF loss from its binding sites. (ii) The presence of 5fC, 
5hmC and 5mC modifications strongly affected the nucleosome/CTCF competition. (iii) A 
spreading of DNA methylation/demethylation and associated deregulation of neighbouring 
genes was observed upon loss of CTCF-binding at boundary elements.  
Common and lost CTCF sites contained the same consensus motif, which was 
characterised by different methylation patterns in WT and DKO cells, consistent with 
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previous observations (Hashimoto et al. 2017). Unlike common CTCF sites, lost sites did not 
have a pronounced CpG in the motif’s center (Figure 2). On the other hand, lost CTCF sites 
had a higher probability of containing methylated CpGs both in WT and DKO cells (Figure 3). 
Furthermore, there were distinct patterns beyond the core CTCF motif: Common CTCF sites 
were embedded in larger regions with high GC and CpG content (presumably CpG islands). 
This is consistent with our previous reports showing that in different mouse and human cell 
types CTCF binding perturbations indicated that CTCF is preferentially retained inside CpG 
islands (Teif et al. 2014; Pavlaki et al. 2018). We have also reported previously that DNA 
methylation canyons – which often overlap with CpG islands (Jeong et al. 2014) – tagged 
with activating chromatin marks are less prone to hypermethylation upon Tet1/2 loss (Wiehle 
et al. 2016). This may account for the particular preservation of CTCF binding in these 
regions with high GC and CpG content. It should also be noted that a previous study 
concluded that CTCF sensitivity to methylation is associated with CpG islands in the human 
HCT116 cell line (Maurano et al. 2015). Accordingly, further studies are needed to assess 
whether these effects are cell-type specific. 
Our quantitative model showed that the affinity of the CTCF motif and nucleosome 
occupancy were both comparable predictors of CTCF loss upon Tet1/2 depletion. However, 
the best predictor was the DNA sequence of a larger ~1 kb region encompassing the CTCF 
binding site (Figure 4). This novel finding may explain why previous models for differential 
CTCF binding based on the modification/occupancy of the core CTCF motif had limited 
predictive power. We also showed that the average profile of DNA-encoded CTCF affinity 
oscillates with the nucleosome repeat length (NRL) periodicity as a function of the distance 
from a CpG. The latter result has important implications, suggesting that regular arrays of 
nucleosomes around CTCF sites may be at least partially encoded in the DNA sequence, 
and are not just a consequence of the boundary conditions on the statistical nucleosome 
density distribution (Figure 5). DNA sequence-encoded nucleosome periodicity near CTCF 
binding sites was proposed in our previous work (Beshnova et al. 2014), and the sequence-
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encoded oscillations described in Figure 5 confirm this hypothesis. The concept that some 
TF binding sites are pre-marked in ESCs for later binding during development by DNA 
hydroxymethylation has also been put forward in a recent study (Kim et al. 2018). How 
exactly this pre-marking is achieved is not known. Our study suggests that the DNA 
sequence not only defines the genomic binding pattern for a given time point, but also at 
least partially determines the future dynamics of differential DNA methylation and TF 
binding.  
Several findings obtained here point to a role of CTCF sites as bifurcation points where the 
smooth differential DNA methylation profile changes its pattern upstream and downstream of 
CTCF in regions that comprise several kb (Figure 6). To our knowledge such asymmetry has 
not been noticed before for genomic regions at this scale. A potentially related effect is the 
asymmetry of hemi-methylated CpGs flanking CTCF binding sites (Xu and Corces 2018). 
Another recent study considered averaged DNA methylation profiles around all TAD or intra-
TAD boundaries and showed that DNA methylation levels smoothly decay as a function of 
the distance to the boundary (Matthews and Waxman 2018). Thus, CTCF might act as a 
DNA methylation insulator element. This happens at a relatively small percentage of DMR 
boundaries that contain CTCF sites, in line with previous reports that some CTCF sites do 
not act as a boundary for methylation spreading (Dickson et al. 2010). It is noted, that CTCF 
can also act as a barrier between chromatin states that are characterized e.g. by H3K27me3 
and H2AK5ac marks (Cuddapah et al. 2009).  
Our observation that CTCF can set bifurcation points for the DNA methylation landscape 
might also explain the recently reported differential silencing of variably methylated repeat 
elements bordered by CTCF (Kazachenka et al. 2018). As depicted in Figure 7F, extended 
genomic regions of changed DNA methylation upstream or downstream of lost CTCF 
“insulator” sites might lead to the deregulation of neighbouring genes (see Figures S27-S31 
for specific examples of such genes). While there was a genome-wide preference for 
upregulation of gene expression in DKO versus WT cells, this trend was reversed inside 
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TADs that lost boundaries (which had more downregulated than downregulated genes). It 
was even more pronounced for genes close to the lost boundaries of TADs and chromatin 
loops, as well as genes which lost CTCF from their promoters (Figure 6A). These results 
align well with two recent knockout studies (Nora et al. 2017; Rao et al. 2017). In one of 
these studies, the removal of the CTCF interaction partner cohesin was linked to 
downregulation of nearby superenhancers (Rao et al. 2017). The second work reported 
large gene expression changes after CTCF knockout, although it did not link them 
mechanistically to CTCF removal (Nora et al. 2017). Thus, the 
5mC/5hmC/5fC/nucleosome/CTCF switch dissected here provides a new mechanistic model 
on how CTCF binding is modulated and how it could affect gene regulation.  
 
Methods 
ESC culture. WT and Tet1/2-deficient (DKO) mouse ES cell lines isolated from WT and 
Tet1/Tet2 double-mutant mice with a mixed 129 and C57BL/6 background (Dawlaty et al., 
2013) were maintained in regular ESC medium as detailed in Supplemental Methods. For 
experiments, cells were trypsinized and pre-plated on gelatin coated dishes three times to 
remove feeders.  
CTCF ChIP-seq was performed as described previously (Wiehle and Breiling 2016) and 
sequenced in 50 bp single-read mode on an Illumina HiSeq 2000 device, as detailed in 
Supplemental Methods.  
MNase-assisted H3 ChIP-seq. Cells were cross-linked with 1% methanol-free formaldehyde 
for 10 min. After quenching with glycine, cells were washed three times with PBS. The cell 
pellet was treated with 40 U MNase for 5 min at 37°C, then stopped with 10× Covaris buffer 
(Covaris Ltd) and chromatin was sheared for 15 min with the Covaris S2 device (burst 200; 
cycle 20%; intensity 8). Immunoprecipitation was performed for ~5 × 106 cells with anti-H3 
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antibody (Abcam #ab1791, Lot: GR103864-1). Then chromatin was treated with RNase A 
and proteinase K. Purified DNA was cloned into Illumina libraries with the NEBNext Ultra 
library preparation kit (NEB). Paired-end reads were sequenced using Illumina HiSeq 2000. 
RNA-seq was performed using total RNA extracted using a DNA-Free RNA Kit (Zymo 
Research) as detailed in Supplemental Methods. Libraries were prepared from RNA of WT 
and DKO ESCs using the TruSeq RNA Sample Preparation Kit v2 (Illumina), clustered on 
cBot (Illumina) using TruSeq SR Cluster Kit v3 and sequenced by single-read 50 bp mode 
on a HiSeq 2000 v3 platform according to Illumina´s instructions. RNA-seq analysis was 
performed in Genomatix (Genomatix GmbH) as detailed in Supplemental Methods. 
Bisulfite sequencing. DNA fragmentation was performed using the Covaris S2 AFA System 
as detailed in Supplemental Methods. End repair of fragmented DNA was carried out using 
the Paired End DNA Sample Prep Kit (Illumina). The ligation of the adaptors was performed 
using the Illumina Early Access Methylation Adaptor Oligo Kit (Illumina). The size selection 
of the adaptor-ligated fragments was done using the E-Gel Electrophoresis System 
(Invitrogen) and a Size Select 2% precast agarose gel (Invitrogen) as detailed in 
Supplemental Methods. For the bisulfite treatment we used the EZ-DNA Methylation Kit 
(Zymo Research) as detailed in Supplemental Methods. The libraries were subsequently 
amplified, using the Fast Start High Fidelity PCR System (Roche) with buffer 2, and Illuminas 
PE1.1 and PE2.1 amplification primers as detailed in Supplemental Methods. Base calling 
was performed with Illumina Casava 1.8.1 software, followed by trimming and quality filtering 
by Shore 0.6.2, and downstream processing by BSmap 2.0 (Xi and Li 2009). The 
computation of methylation ratios was done with the script methratio.py (part of the BSmap 
package). In the downstream analysis commonly methylated CpGs were defined as those 
with methylation ≥0.8 in both cell states; gained 5mC – with methylation <0.2 in WT and >0.5 
in DKO cells; lost 5mC – with methylation >0.5 in WT and <0.2 in DKO ESCs; commonly 
unmethylated – with methylation <0.2 in both states. 
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Western Blot. WT and DKO ESCs were lysed and fractionated as described previously 
(Wysocka et al. 2001). The chromatin fraction was resolved by standard SDS-PAGE and 
membranes were immunostained using antibodies against CTCF (#61311, Active Motif) and 
H3 (Abcam ab1791, Lot: GR232149). 
Nucleosome occupancy analysis. Paired-end H3 ChIP-seq reads were mapped to the 
mouse genome mm9 using Bowtie (Langmead et al. 2009) allowing up to two mismatches 
and only unique alignments. This resulted in total 343 and 316 million mapped mono-
nucleosome fragments correspondingly in WT and DKO cells (including two biological 
replicates both for WT cells and for DKO cells). Reads were then processed using the 
NucTools pipeline (Vainshtein et al. 2017) as detailed in Supplemental Methods.  
CTCF ChIP-seq analysis. After mapping reads Bowtie (Langmead et al. 2009) allowing up to 
two mismatches and only unique alignments, we obtained 58 million mapped reads in WT (2 
biological replicates named WT4 and WT6 and an additional technical replicate in WT6) and 
33 million reads in DKO ESCs (2 replicates named DKO26 and DKO51). CTCF peaks were 
determined with MACS (Zhang et al. 2008) using default parameters as detailed in 
Supplemental Methods. Lost sites were defined as appearing in all replicates in WT while 
not appearing in any of DKO replicates. Gained sites were defined as appearing in all 
replicates in DKO and not appearing in any of WT replicates. Locations of CTCF motifs 
within CTCF peaks were determined by scanning for the CTCF motif from JASPAR 
(Mathelier et al. 2016) using RSAT with default parameters (Castro-Mondragon et al. 2017). 
CTCF affinity calculation. For the CTCF binding affinity calculation, we implemented a 
MATLAB version of the TRAP algorithm described elsewhere (Roider et al. 2007), as 
detailed in Supplemental Methods. The choice of the TRAP constant R0 = 109 and the 
energy mismatch scale λ = 1.5 were the same as in our previous work (Teif et al. 2014), with 
the CTCF PWM taken from the JASPAR database (Mathelier et al. 2016). Clustering of the 
unsmoothed CTCF affinity profiles was performed using ClusterMapsBuilder in NucTools 
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(Vainshtein et al. 2017), on a sample of 200,000 available affinity profiles for each case 
based on the values of the logarithm of the predicted affinity. For the background clustering 
control, a set of 50,000 random genomic region sample was generated using BEDTools 
(Quinlan 2014). Receiver-Operator Curves were calculated using Origin 2018 (OriginLab) as 
detailed in Supplemental Methods. 
Gene Ontology analysis was performed with Enrichr (Kuleshov et al. 2016) and DAVID v 6.7 
(Huang da et al. 2009) as detailed in Supplemental Methods. Adjusted Benjamini p-values 
were used throughout the manuscript unless stated otherwise in the text. 
DMR calling. To determine differentially methylated regions we used the R/Bioconductor 
package DMRcaller (Catoni et al. 2018) with a sliding window of 1000bp calling all regions 
where the average methylation level in a given window deviated between WT and DKO cells 
by more than 10%. 
External datasets. 5hmC map in WT ESCs was taken from GSM882244 (Yu et al. 2012). 
5fC maps in WT ESCs were taken from GSE41545 (Song et al. 2013) (used in our Figure 1) 
and from GSE66144 (Xia et al. 2015). 5caC was taken from (Shen et al. 2013). TET1 
binding sites in WT ESCs were taken from GSM611192 (Williams et al. 2011). All these 
datasets were aligned by their authors to the mm9 mouse genome. Hi-C data determining 
the boundaries of topologically associated domains (TADs) and promoter-enhancer loops 
were taken from (Bonev et al. 2017). These were initially aligned to GRCm38 (mm10) and 
we have converted them to mm9 using liftOver tool of the UCSC Genome Browser in order 
to use mm9 for all manipulations in this manuscript. Realigning the reads to mm10 would not 
significantly affect the conclusions because the coordinates of most genomic regions could 
be uniquely converted between these two genome assemblies. 
 
Data access 
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The raw sequencing data generated in this study have been submitted to the Gene 
Expression Omnibus (GEO; https://www.ncbi.nlm.nih. gov/geo/) under accession numbers 
GSE110460 (bisulfite sequencing) and GSE114599 (ChIP-seq and RNA-seq). Scripts 
developed in this study have been uploaded as Supplemental Code and are also available 
at https://github.com/TeifLab/TFaffinity. 
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Figure Legends 
 
Figure 1. DNA methylation is associated with nucleosome repositioning. A and B) 
Relative DNA methylation is shown around centers of 100-bp genomic regions with lost (A) 
and gained nucleosome occupancy (B). C-F) Changes in DNA methylation were associated 
with shifted nucleosomes. Relative DNA methylation is plotted as a function of the distance 
from the centers of nucleosomes on Chromosome 19 determined by paired-end MNase-
assisted H3 ChIP-seq. Black lines – DNA methylation in WT. Red lines – DNA methylation in 
DKO ESCs. Within each plot WT and DKO methylation was normalised in the same way and 
is quantitatively comparable. C) Common nucleosomes whose boundaries change <5% 
between WT and DKO ESCs (>95% overlap between the bodies of the corresponding 
paired-end reads in WT and DKO cells). D) Nucleosomes in WT cells whose boundaries 
were changed in DKO by >5% (<95% overlap). E) Nucleosomes in WT cells whose 
boundaries were changed in DKO by >30% (<70% overlap). F) All nucleosomes in DKO 
ESCs. G) Fold enrichment of lost/gained nucleosomes at different genomic features. H) Fold 
enrichment of common/gained/lost 5mC at genomic features. 
Figure 2. Loss of CTCF is associated with reduced GC content and CpG density. A, B) 
Fold enrichment (A) and percent overlap (B) of lost/common CTCF sites with different 
genomic features. CTCF sites are defined as 19-nucleotide motifs within the corresponding 
CTCF ChIP-seq peaks. (C, D) The nucleotide frequencies within +/-2,000 bp around CTCF 
motifs in common (C) and lost (D) peaks, and the corresponding consensus motifs. (E, F) 
CpG density around CTCF motifs in common and lost sites. Black dots correspond to 
individual CpG positions, red lines represent a spline interpolation of their density, and blue 
arrows indicate the outstanding CpGs inside the CTCF binding motif together with their 
coordinates with respect to the central peak of CpG density. 
Figure 3. Genome-wide CTCF rearrangement happens preferentially at CpGs which 
gain methylation in DKO ESCs. (A) The average CTCF occupancy profiles around 
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commonly methylated CpGs (methylation >0.8 both in WT and DKO cells; N = 10,505,682). 
(B) Depletion of CTCF occupancy around CpGs which gain methylation in DKO ESCs 
(<20% methylation in WT, >50% methylation in DKO cells; N = 9,739,847). CTCF profiles 
have been first calculated for individual replicate experiments, and then averaged for all 
available replicates correspondingly for each cell type. Grey/pink shaded areas show the 
standard deviations of this averaging. (C-F) 5mC density around common and lost CTCF 
motifs in WT and DKO cells. Black dots correspond to individual CpG positions, red lines 
represent a spline interpolation of their density, and blue arrows indicate outstanding CpGs 
inside the CTCF binding motif. 
Figure 4. CTCF loss in DKO ESCs is predetermined by weaker DNA sequence 
affinities at a subset of lost sites. A, B) Normalized average CTCF occupancy profiles 
around common and lost CTCF sites in WT (A) and DKO cells (B). Black line – common 
sites, red line – lost sites. Grey and pink shaded areas show the corresponding standard 
deviation. (C) Normalized average nucleosome occupancy profiles around common and lost 
CTCF sites in WT and DKO ESCs. Blue arrows show that nucleosome occupancy at lost 
sites was higher than at common sites both in WT and DKO cells, but in DKO ESCs this 
difference becomes larger. (D) CTCF affinity predicted by the biophysical model from the 
DNA sequence for regions around common and lost CTCF sites was about two-fold higher 
for common sites.  
Figure 5. CTCF-DNA binding affinity predicted from the DNA sequence as a function 
of distance from CpGs. A-B) Calculations performed for four classes of CpGs genome-
wide. A) CpGs that were commonly methylated in both cell states (methylation >0.8 both in 
WT and DKO cells; N = 10,439,081), that gained methylation (<0.2 in WT and >0.5 in DKO 
ESCs; N = 9,596,997) and that lost methylation (>0.5 in WT and <0.2 in DKO ESCs; 
N = 6,859,738). B) Unmethylated CpGs (<0.2 in both WT and DKO; N = 15,316,892). C-F) 
Calculations performed only for CpGs within CTCF ChIP-seq peaks in WT. C) Common 
5mC sites inside common (N = 25,740) and lost CTCF peaks (N = 33,060). D) Gained 5mC 
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sites inside common (N = 37,702) and lost CTCF peaks (N = 35,518). E) Lost 5mC sites 
inside common (N = 35,632) and lost CTCF peaks (N = 35,527). F) Unmethylated CpGs 
inside common (N = 460,752) and lost CTCF peaks (N = 179,288). 
Figure 6. Tet1/2 knockout changes DNA methylation profiles separated by CTCF and 
influences gene expression. (A) Changes of gene expression upon Tet1/2-dependent loss 
of CTCF from functional genomic regions. The bars show percentages of up- and 
downregulated transcripts with respect to all transcripts overlapping with a given feature. The 
values on the bar indicate the corresponding numbers of transcripts in each category. Bars 
numbered left to right: (1) all transcripts genome-wide; (2) transcripts inside all TADs; (3) 
transcripts within 10 kb from any loop boundary; (4) transcripts within 10 kb from any TAD 
boundary; (5) transcripts located within TADs that lost a boundary (a boundary was called 
lost if there was at least one lost CTCF site within 10 kb from the boundary); (6) transcripts 
within 10 kb from any lost loop boundary based on the same criterion for the boundary loss; 
(7) transcripts within 10 kb from any lost TAD boundary based on the criterion for the 
boundary loss; (8) transcripts that lost CTCF from their promoters. The yellow area indicates 
features that lost CTCF. The red points correspond to the ratio of the numbers of down- 
versus up-regulated transcripts indicated on the right axis. B-D) Example genomic regions 
showing the DNA methylation pattern smoothed with a 500-bp sliding window, as it changes 
between WT and DKO cells. Thick dashed lines show average 5mC level per CpG, and solid 
lines show CTCF occupancy in WT (black) and DKO ESCs (red). Thin blue dashed lines 
indicate peaks of CTCF occupancy. Some of these coincide with chromatin loop borders 
reported by Bonev et al. (indicated on the figure). Light blue rectangle shows the gene body. 
The arrow indicates direction of transcription. Gene expression changes are indicated in the 
figure. E-F) DNA methylation profiles in WT (black) and DKO cells (red) around centers of 
1000-bp regions that were characterised by increased (“gain”) or decreased methylation 
(“loss”) in DKO ESCs. G-H) Average CTCF occupancy profiles around “gain” and “loss” 
DMRs, showing that “gain” DMRs tended to be flanked by CTCF sites. The same effect was 
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observed for “loss” DMRs, but was less evident due to a fraction of CTCF sites located in the 
middle of “loss” DMRs. 
Figure 7. A scheme of different regimes of CTCF sensitivity to DNA modifications. (A) 
Simplified scheme of the possible causality of events: Tet1/2 knockout leads to the changed 
DNA methylation pattern and increased nucleosome occupancy. These lead to CTCF 
binding loss at variable sites. As a result methylation spreads to larger areas and 
neighbouring genes are downregulated. (B) Common CTCF sites were significantly enriched 
at CpG islands where DNA was unmethylated in both cell types and CTCF binding was 
mostly determined by the DNA sequence. (C) CTCF sites marked by 5hmC in WT were 
predisposed for loss of CTCF binding in DKO cells, which could be accompanied by a 
5hmC/5mC switch and the loss of 5hmC. (D) Regions near 5fC sites were more enriched for 
common than for lost CTCF sites. (E) CTCF loss at promoters and in the vicinity of genes 
may lead to the spreading of DNA methylation into neighbouring regions as a function of the 
distance from the CTCF site. Genes inside such regions tend to become downregulated in 
DKO ESCs. (F) In some cases methylation of a single CpG inside a CTCF binding site may 
lead to CTCF removal, or vice versa, and results in the loss of the boundary between 
methylation microdomains. This process may induce a subsequent change of transcription, 
as shown for an example genomic region in Figure S27. 
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